{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T20:19:34Z","timestamp":1760473174811,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00467-022-05822-9","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T15:03:01Z","timestamp":1671634981000},"page":"3183-3187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sex differences of burosumab in children with X-linked hypophosphataemic rickets"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1891-6765","authenticated-orcid":false,"given":"Guido","family":"Filler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Shi Han","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"5822_CR1","first-page":"17","volume":"17","author":"A Gohil","year":"2019","unstructured":"Gohil A, Imel EA (2019) FGF23 and associated disorders of phosphate wasting. Pediatr Endocrinol Rev 17:17\u201334","journal-title":"Pediatr Endocrinol Rev"},{"key":"5822_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/sj.ejhg.5200341","volume":"7","author":"D Filisetti","year":"1999","unstructured":"Filisetti D, Ostermann G, Von Bredow M, Strom T, Filler G, Ehrich J, Pannetier S, Garnier JM, Rowe P, Francis F, Julienne A, Hanauer A, Econs MJ, Oudet C (1999) Non-random distribution of mutations in the PHEX gene, end under-detected missense mutations at non-conserved residues. Eur J Hum Genet 7:615\u2013619","journal-title":"Eur J Hum Genet"},{"key":"5822_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00005792-195805000-00001","volume":"37","author":"RW Winters","year":"1958","unstructured":"Winters RW, Graham JB, Williams TF, McFalls VW, Burnett CH (1958) A genetic study of familial hypophosphatemia and vitamin D resistant rickets with a review of the literature. Medicine (Baltimore) 37:97\u2013142","journal-title":"Med"},{"key":"5822_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12325-019-01170-7","volume":"37","author":"P Arango Sancho","year":"2020","unstructured":"Arango Sancho P (2020) Complications of phosphate and vitamin D treatment in X-linked hypophosphataemia. Adv Ther 37:105\u2013112","journal-title":"Adv Ther"},{"key":"5822_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1210\/js.2018-00338","volume":"3","author":"GP Colares Neto","year":"2019","unstructured":"Colares Neto GP, Ide Yamauchi F, Hueb Baroni R, de Andrade BM, Cavalanti Gomes A, Chammas MC, Matsunaga Martin R (2019) Nephrocalcinosis and nephrolithiasis in X-linked hypophosphatemic rickets: diagnostic imaging and risk factors. J Endocr Soc 3:1053\u20131061","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"5822_CR6","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1530\/EJE-08-0383","volume":"159","author":"H Raeder","year":"2008","unstructured":"Raeder H, Shaw N, Netelenbos C, Bjerknes R (2008) A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Eur J Endocrinol 159(Suppl 1):S101\u2013S105","journal-title":"Eur J Endocrinol"},{"key":"5822_CR7","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Hogler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393:2416\u20132427","journal-title":"Lancet"},{"key":"5822_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"Insogna KL, Briot K, Imel EA, Kamenicky P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-Oklota C, Mealiffe M, San Martin J, Carpenter TO, AXLES 1 Investigators (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33:1383\u20131393","journal-title":"J Bone Miner Res"},{"key":"5822_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","volume":"105","author":"AA Portale","year":"2019","unstructured":"Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K (2019) Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period. Calcif Tissue Int 105:271\u2013284","journal-title":"Calcif Tissue Int"},{"key":"5822_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ajmg.a.20572","volume":"126A","author":"E Pronicka","year":"2004","unstructured":"Pronicka E, Popowska E, Rowinska E, Arasimowicz E, Syczewska M, Jurkiewicz D, Lebiedowski M (2004) Anthropometric characteristics of X-linked hypophosphatemia. Am J Med Genet A 126A:141\u2013149","journal-title":"Am J Med Genet A"},{"key":"5822_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00862587","volume":"2","author":"J Brodehl","year":"1988","unstructured":"Brodehl J, Krause A, Hoyer PF (1988) Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet. Pediatr Nephrol 2:183\u2013189","journal-title":"Pediatr Nephrol"},{"key":"5822_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","volume":"46","author":"TD Thacher","year":"2000","unstructured":"Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Manaster BJ, Reading JC (2000) Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr 46:132\u2013139","journal-title":"J Trop Pediatr"},{"key":"5822_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bone.2019.01.021","volume":"121","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao Z, Sun Y, Xu L, JiaJue R, Cui L, Pang Q, Jiang Y, Li M, Wang O, He X, He S, Nie M, Xing X, Meng X, Zhou X, Yan L, Kaplan JM, Insogna KL, Xia W (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121:212\u2013220","journal-title":"Bone"},{"key":"5822_CR14","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00467-022-05505-5","volume":"37","author":"D Haffner","year":"2022","unstructured":"Haffner D, Leifheit-Nestler M, Grund A, Schnabel D (2022) Rickets guidance: part II-management. Pediatr Nephrol 37:2289\u20132302","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05822-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T07:02:57Z","timestamp":1692169377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5822"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05822-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"27 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"G Filler received a speaker honorarium from Ultragenyx Inc. and serves on the Ultragenyx Advisory Board. No other authors have conflicts of interest relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The manuscript was prepared and conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The study was approved by the local ethics research board (file number 118344, PI G Filler, last approved 03 May 2022). Although the need for informed consent was waived by the ethics committee, each family was consented verbally for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}